Company profile: IPM.ai
1.1 - Company Overview
Company description
- Provider of HIPAA-certified machine learning infrastructure for biopharma, delivering AI-powered patient finding, insights-as-a-service, and a system of insight using real-world data to optimize drug development and commercialization. Services include clinical study recruitment, market assessment, and patient journey mapping for specialty and rare diseases.
Products and services
- AI-Powered Patient Finding: Employs patented HIPAA-certified machine learning to identify and profile specialty and rare disease patients, including undiagnosed or non-adherent-at-risk cohorts, enabling precise Ideal Patient Population discovery
- System of Insight: Constructs a real-world data-driven AI platform that analyzes patient journeys and healthcare ecosystems to optimize drug development and commercialization decisions across therapeutic interventions
- Insights-as-a-Service: Supplies machine learning-enabled, data-driven intelligence for specialty and rare diseases, helping life sciences companies comprehend patient populations and treatment journeys to inform commercialization and marketing strategies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IPM.ai
Roam Analytics
HQ: United States
Website
- Description: Provider of a proprietary artificial intelligence platform for healthcare that transforms patient and physician pathway analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roam Analytics company profile →
Title21
HQ: United States
Website
- Description: Provider of fully integrated, flexible software for health science organizations to increase operational efficiency, close compliance gaps, and improve patient care. Products include cellular therapy and BMT data management platforms; quality management (document control, CAPA, audit, training); audit management; equipment management for preventive maintenance and calibration; and web-based CAPA software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Title21 company profile →
Ovation
HQ: United States
Website
- Description: Provider of a cloud-based LIMS for molecular diagnostic laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ovation company profile →
CLC Bio
HQ: Denmark
Website
- Description: Provider of bioinformatics solutions focused on analyzing data from all major high-throughput sequencing machines, including instruments from Illumina, Applied Biosystems (LIFE Technologies), Roche 454, Helicos, and Sanger.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CLC Bio company profile →
Health Language
HQ: United States
Website
- Description: Provider of enterprise terminology management solutions and professional services for healthcare organizations, offering software, content, and consulting to normalize data by mapping, translating, updating, and managing clinical terminologies. Solutions include point-of-care code accuracy, data interoperability, analytics integrity, risk adjustment NLP, regulatory audit support, and consumer-friendly code descriptions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Language company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IPM.ai
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IPM.ai
2.2 - Growth funds investing in similar companies to IPM.ai
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IPM.ai
4.2 - Public trading comparable groups for IPM.ai
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →